CAS 1058653-74-9

5-[5-(2-Chloroacetyl)-2-ethoxyphenyl]-1,6-dihydro-1-Methyl-3-propyl-7H-pyrazolo[4,3-d]pyriMidin-7-one

CAS : 1058653-74-9

Formule : C₁₉H₂₁ClN₄O₃

Couleur et forme : Solid

Masse moléculaire : 388.8480

Ref: IN-DA008W6J

Chlorodenafil

CAS : 1058653-74-9

Formule : C₁₉H₂₁ClN₄O₃

Couleur et forme : Pale Pink Solid

Masse moléculaire : 388.85

Ref: 4Z-S-0633

Chlorodenafil

CAS : 1058653-74-9

Formule : C₁₉H₂₁ClN₄O₃

Couleur et forme : Neat

Masse moléculaire : 388.85

Ref: 04-C11398500

Chlorodenafil

Produit contrôlé

CAS : 1058653-74-9

Applications Chlorodenafil is a related compound of Sildenafil (S435000) as phosphodiesterase inhibitor.
References Childress, S., et al.: J. Pharm. Sci., 53, 577 (1964), Phillips, O., et al.: Can. J. Chem., 77, 216 (1999),

Formule : C₁₉H₂₁ClN₄O₃

Couleur et forme : Off White Solid

Masse moléculaire : 388.85

Ref: TR-C365535

Chlorodenafil

CAS : 1058653-74-9

Chlorodenafil is an analog of tadalafil, a PDE-5 inhibitor. It is used in the treatment of erectile dysfunction. The safety and efficacy of chlorodenafil have not been established. This drug is not recommended for use by patients with severe hepatic impairment or those who are taking medicines that inhibit CYP3A4. Chlorodenafil should not be used with other PDE-5 inhibitors, such as sildenafil and vardenafil, because this can lead to a serious decrease in blood pressure.
Chlorodenafil has been investigated for its possible role in the treatment of dyslipidemia and insulin resistance; however, it has not been approved for these indications.

Formule : C₁₉H₂₁ClN₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 388.8 g/mol

Ref: 3D-ISB65374

Chlorodenafil

CAS : 1058653-74-9

Chlorodenafil is a related compound of Sildenafil -- a phosphodiesterase inhibitor.

Formule : C₁₉H₂₁ClN₄O₃

Couleur et forme : Solid

Masse moléculaire : 388.85

Ref: TM-T71519

Sildenafil Chloroacetyl Impurity

CAS : 1058653-74-9

Formule : C₁₉H₂₁ClN₄O₃

Masse moléculaire : 388.85

Ref: ST-EA-CP-S2010